Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.
about
Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSedentary behavior and health outcomes: an overview of systematic reviewsNovel methodologies for biomarker discovery in atherosclerosisSerum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease.1,25-Vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathway.Comparison of heritability of Cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease.Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity.Impact of different dietary approaches on glycemic control and cardiovascular risk factors in patients with type 2 diabetes: a protocol for a systematic review and network meta-analysis.Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects.The effect of periodontal therapy on C-reactive protein, endothelial function, lipids and proinflammatory biomarkers in patients with stable coronary artery disease: study protocol for a randomized controlled trial.Mind and body: how the health of the body impacts on neuropsychiatry.Vitamin D status and hypercholesterolemia in Spanish general population.Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding.Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.Microfluidic platforms for biomarker analysis.Targeting MMP-2 to treat ischemic heart injury.Review on cardiovascular risk prediction.Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among Women.Accurate Quantification of Disease Markers in Human Serum Using Iron Oxide Nanoparticle-linked Immunosorbent Assay.Serum Cystatin C and the Risk of Coronary Heart Disease in Ethnic Chinese Patients With Normal Renal Function.Effects of aerobic and resistance training on abdominal fat, apolipoproteins and high-sensitivity C-reactive protein in adolescents with obesity: the HEARTY randomized clinical trial.Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction.Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease.Pregnancy associated plasma protein-A as a prognostic biomarker of all-cause mortality and cardiovascular events in patients presenting with chest pain: a systematic review.Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk
P2860
Q26827245-A0FA3A3E-2116-412A-8E95-F40E8A16C0EDQ27022664-813B108E-0DAC-4288-AF1D-AEED130809A0Q28088373-7ACB6A56-3270-45D1-9FB0-77AB3502F149Q34145836-5DF76134-9E5C-4D21-AEB5-024E648147A7Q34345326-189FFEC0-BDC5-4D14-A9A6-AEA514064D14Q35088150-9BD69F33-2608-4FE1-8F77-49D900509DF5Q35176319-4194235C-43D1-4D26-B9F6-74A9111AAD95Q36315487-A76420AA-AA63-47B4-9880-D0D2759A50FCQ36543097-7B933E45-D93F-4937-A279-84F15128CC0CQ36824744-F70EC333-133E-4819-978B-DA2D7A8E967FQ37351901-9F6B17F3-8D0E-4E1A-9AEA-A22B817DA4A8Q37399776-CCC2647F-83D8-4330-A88F-F8D25BB579D1Q37538281-C5BB2C6E-1F2B-4570-91A0-00E0825BE9FAQ37578658-51E04577-D051-4EE0-827F-D408A9C778F9Q37692590-84677C95-BF2C-4790-84A5-A123126B563AQ38198962-299E8983-0BCB-44E2-9ED7-F6141544C401Q38225432-1B3C6B1E-D91C-47D1-8448-9A79B4787AE8Q38373055-AD398055-3A23-434D-B112-F66ECA2623F9Q39729247-015DA8F4-8975-4071-9679-926A5563D25FQ40626404-3DEE3FB5-04B8-4E50-912E-00198D59A99BQ40998882-F5421916-137C-4F3B-8642-F4FB1919A4C7Q41557191-AD22E0EF-66A5-44FA-8DC4-1C89D85A9E19Q43148428-6AC2C6C1-3C01-4E84-9FD6-0F7FD1FD1688Q46312965-0E30E754-E059-46C4-B4F3-BB1CDBE30D6CQ47396735-87AEF324-F3C5-40AB-8FB2-14C1224AE647Q58800768-30451C53-2080-4F27-8FC2-B91F9FCD1398
P2860
Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@ast
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@en
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@nl
type
label
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@ast
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@en
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@nl
prefLabel
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@ast
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@en
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@nl
P2093
P2860
P31
P921
P1433
P1476
Circulating biomarkers for pre ...... ive overview of meta-analyses.
@en
P2093
Imo E Hoefer
Joost Vissers
Leonie F Waanders
Mark Roest
Menno W J Prins
Philip G de Groot
Thijs C van Holten
P2860
P304
P356
10.1371/JOURNAL.PONE.0062080
P407
P5008
P577
2013-04-22T00:00:00Z